Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × tazemetostat × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Sarcoma, Synovial 1 Sarcoma 1

Interventions

entrectinib 2 venetoclax 1 trametinib 1 tazemetostat 1 selpercatinib 1 ripretinib 1 repotrectinib 1 pirtobrutinib 1 pembrolizumab 1 larotrectinib 1 dabrafenib 1 avapritinib 1 atezolizumab 1 Taxes 1 Specimen Handling 1 Rituximab 1 Paclitaxel 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02601950 2025-06-22

A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Ipsen

Phase 2 Completed

267 enrolled 25 charts 2 FDA

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡